Intermittent Etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH agonist.

Zamberlan, N

Intermittent Etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH agonist. [electronic resource] - Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1997 - 133-7 p. digital

Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0937-941X

10.1007/BF01623688 doi


Adult
Anthropometry
Bone Density--drug effects
Calcium--therapeutic use
Drug Therapy, Combination
Etidronic Acid--therapeutic use
Female
Hirsutism--drug therapy
Humans
Luteolytic Agents--adverse effects
Osteoporosis--chemically induced
Polycystic Ovary Syndrome--drug therapy
Triptorelin Pamoate--adverse effects